Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study Article Swipe
Jehan Dupuis
,
Emmanuel Bachy
,
Franck Morschhauser
,
Guillaume Cartron
,
Noriko Fukuhara
,
Nicolas Daguindau
,
Olivier Casasnovas
,
Sylvia Snauwaert
,
Rémy Gressin
,
Christopher P. Fox
,
Francesco d’Amore
,
Philipp B. Staber
,
Olivier Tournilhac
,
Krimo Bouabdallah
,
Catherine Thieblemont
,
Marc André
,
Shinya Rai
,
Daisuke Ennishi
,
Argyrios Gkasiamis
,
Mitsufumi Nishio
,
Luc‐Matthieu Fornecker
,
Marie‐Hélène Delfau‐Larue
,
Nouhoum Sako
,
Sebastien Mulé
,
Laurence de Leval
,
Philippe Gaulard
,
Kunihiro Tsukasaki
,
François Lemonnier
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1016/s2352-3026(24)00102-9
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1016/s2352-3026(24)00102-9
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/s2352-3026(24)00102-9
- OA Status
- green
- Cited By
- 18
- References
- 29
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4398244654
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4398244654Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/s2352-3026(24)00102-9Digital Object Identifier
- Title
-
Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 studyWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-05-23Full publication date if available
- Authors
-
Jehan Dupuis, Emmanuel Bachy, Franck Morschhauser, Guillaume Cartron, Noriko Fukuhara, Nicolas Daguindau, Olivier Casasnovas, Sylvia Snauwaert, Rémy Gressin, Christopher P. Fox, Francesco d’Amore, Philipp B. Staber, Olivier Tournilhac, Krimo Bouabdallah, Catherine Thieblemont, Marc André, Shinya Rai, Daisuke Ennishi, Argyrios Gkasiamis, Mitsufumi Nishio, Luc‐Matthieu Fornecker, Marie‐Hélène Delfau‐Larue, Nouhoum Sako, Sebastien Mulé, Laurence de Leval, Philippe Gaulard, Kunihiro Tsukasaki, François LemonnierList of authors in order
- Landing page
-
https://doi.org/10.1016/s2352-3026(24)00102-9Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://pure.au.dk/portal/en/publications/080ee718-8915-41f7-83bc-fd7117004f02Direct OA link when available
- Concepts
-
Medicine, Azacitidine, Open label, Refractory (planetary science), Internal medicine, Follicular lymphoma, Oncology, Follicular phase, Phases of clinical research, Lymphoma, Clinical trial, Biochemistry, DNA methylation, Astrobiology, Physics, Gene, Chemistry, Gene expressionTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
18Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 15, 2024: 3Per-year citation counts (last 5 years)
- References (count)
-
29Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4398244654 |
|---|---|
| doi | https://doi.org/10.1016/s2352-3026(24)00102-9 |
| ids.doi | https://doi.org/10.1016/s2352-3026(24)00102-9 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38796193 |
| ids.openalex | https://openalex.org/W4398244654 |
| fwci | 16.48457832 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D008297 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Male |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D005260 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Female |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D000368 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Aged |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D008875 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Middle Aged |
| mesh[5].qualifier_ui | Q000627 |
| mesh[5].descriptor_ui | D001374 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | therapeutic use |
| mesh[5].descriptor_name | Azacitidine |
| mesh[6].qualifier_ui | Q000009 |
| mesh[6].descriptor_ui | D001374 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | adverse effects |
| mesh[6].descriptor_name | Azacitidine |
| mesh[7].qualifier_ui | Q000008 |
| mesh[7].descriptor_ui | D001374 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | administration & dosage |
| mesh[7].descriptor_name | Azacitidine |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D000284 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Administration, Oral |
| mesh[9].qualifier_ui | Q000627 |
| mesh[9].descriptor_ui | D000069461 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | therapeutic use |
| mesh[9].descriptor_name | Bendamustine Hydrochloride |
| mesh[10].qualifier_ui | Q000008 |
| mesh[10].descriptor_ui | D000069461 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | administration & dosage |
| mesh[10].descriptor_name | Bendamustine Hydrochloride |
| mesh[11].qualifier_ui | Q000009 |
| mesh[11].descriptor_ui | D000069461 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | adverse effects |
| mesh[11].descriptor_name | Bendamustine Hydrochloride |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D000093542 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Gemcitabine |
| mesh[13].qualifier_ui | Q000188 |
| mesh[13].descriptor_ui | D008224 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | drug therapy |
| mesh[13].descriptor_name | Lymphoma, Follicular |
| mesh[14].qualifier_ui | Q000401 |
| mesh[14].descriptor_ui | D008224 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | mortality |
| mesh[14].descriptor_name | Lymphoma, Follicular |
| mesh[15].qualifier_ui | Q000031 |
| mesh[15].descriptor_ui | D003841 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | analogs & derivatives |
| mesh[15].descriptor_name | Deoxycytidine |
| mesh[16].qualifier_ui | Q000627 |
| mesh[16].descriptor_ui | D003841 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | therapeutic use |
| mesh[16].descriptor_name | Deoxycytidine |
| mesh[17].qualifier_ui | Q000008 |
| mesh[17].descriptor_ui | D003841 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | administration & dosage |
| mesh[17].descriptor_name | Deoxycytidine |
| mesh[18].qualifier_ui | Q000009 |
| mesh[18].descriptor_ui | D003841 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | adverse effects |
| mesh[18].descriptor_name | Deoxycytidine |
| mesh[19].qualifier_ui | Q000627 |
| mesh[19].descriptor_ui | D047630 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | therapeutic use |
| mesh[19].descriptor_name | Depsipeptides |
| mesh[20].qualifier_ui | Q000009 |
| mesh[20].descriptor_ui | D047630 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | adverse effects |
| mesh[20].descriptor_name | Depsipeptides |
| mesh[21].qualifier_ui | Q000008 |
| mesh[21].descriptor_ui | D047630 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | administration & dosage |
| mesh[21].descriptor_name | Depsipeptides |
| mesh[22].qualifier_ui | Q000627 |
| mesh[22].descriptor_ui | D000971 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | therapeutic use |
| mesh[22].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[23].qualifier_ui | Q000009 |
| mesh[23].descriptor_ui | D000971 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | adverse effects |
| mesh[23].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[24].qualifier_ui | Q000627 |
| mesh[24].descriptor_ui | D000964 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | therapeutic use |
| mesh[24].descriptor_name | Antimetabolites, Antineoplastic |
| mesh[25].qualifier_ui | Q000009 |
| mesh[25].descriptor_ui | D000964 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | adverse effects |
| mesh[25].descriptor_name | Antimetabolites, Antineoplastic |
| mesh[26].qualifier_ui | Q000008 |
| mesh[26].descriptor_ui | D000964 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | administration & dosage |
| mesh[26].descriptor_name | Antimetabolites, Antineoplastic |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D000369 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Aged, 80 and over |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D006801 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Humans |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D008297 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Male |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D005260 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Female |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D000368 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Aged |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D008875 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Middle Aged |
| mesh[33].qualifier_ui | Q000627 |
| mesh[33].descriptor_ui | D001374 |
| mesh[33].is_major_topic | True |
| mesh[33].qualifier_name | therapeutic use |
| mesh[33].descriptor_name | Azacitidine |
| mesh[34].qualifier_ui | Q000009 |
| mesh[34].descriptor_ui | D001374 |
| mesh[34].is_major_topic | True |
| mesh[34].qualifier_name | adverse effects |
| mesh[34].descriptor_name | Azacitidine |
| mesh[35].qualifier_ui | Q000008 |
| mesh[35].descriptor_ui | D001374 |
| mesh[35].is_major_topic | True |
| mesh[35].qualifier_name | administration & dosage |
| mesh[35].descriptor_name | Azacitidine |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D000284 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Administration, Oral |
| mesh[37].qualifier_ui | Q000627 |
| mesh[37].descriptor_ui | D000069461 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | therapeutic use |
| mesh[37].descriptor_name | Bendamustine Hydrochloride |
| mesh[38].qualifier_ui | Q000008 |
| mesh[38].descriptor_ui | D000069461 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | administration & dosage |
| mesh[38].descriptor_name | Bendamustine Hydrochloride |
| mesh[39].qualifier_ui | Q000009 |
| mesh[39].descriptor_ui | D000069461 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | adverse effects |
| mesh[39].descriptor_name | Bendamustine Hydrochloride |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D000093542 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Gemcitabine |
| mesh[41].qualifier_ui | Q000188 |
| mesh[41].descriptor_ui | D008224 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | drug therapy |
| mesh[41].descriptor_name | Lymphoma, Follicular |
| mesh[42].qualifier_ui | Q000401 |
| mesh[42].descriptor_ui | D008224 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | mortality |
| mesh[42].descriptor_name | Lymphoma, Follicular |
| mesh[43].qualifier_ui | Q000031 |
| mesh[43].descriptor_ui | D003841 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | analogs & derivatives |
| mesh[43].descriptor_name | Deoxycytidine |
| mesh[44].qualifier_ui | Q000627 |
| mesh[44].descriptor_ui | D003841 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | therapeutic use |
| mesh[44].descriptor_name | Deoxycytidine |
| mesh[45].qualifier_ui | Q000008 |
| mesh[45].descriptor_ui | D003841 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | administration & dosage |
| mesh[45].descriptor_name | Deoxycytidine |
| mesh[46].qualifier_ui | Q000009 |
| mesh[46].descriptor_ui | D003841 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | adverse effects |
| mesh[46].descriptor_name | Deoxycytidine |
| mesh[47].qualifier_ui | Q000627 |
| mesh[47].descriptor_ui | D047630 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | therapeutic use |
| mesh[47].descriptor_name | Depsipeptides |
| mesh[48].qualifier_ui | Q000009 |
| mesh[48].descriptor_ui | D047630 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | adverse effects |
| mesh[48].descriptor_name | Depsipeptides |
| mesh[49].qualifier_ui | Q000008 |
| mesh[49].descriptor_ui | D047630 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | administration & dosage |
| mesh[49].descriptor_name | Depsipeptides |
| type | article |
| title | Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study |
| biblio.issue | 6 |
| biblio.volume | 11 |
| biblio.last_page | e414 |
| biblio.first_page | e406 |
| grants[0].funder | https://openalex.org/F4320307115 |
| grants[0].award_id | |
| grants[0].funder_display_name | Bristol-Myers Squibb |
| topics[0].id | https://openalex.org/T10185 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2734 |
| topics[0].subfield.display_name | Pathology and Forensic Medicine |
| topics[0].display_name | Lymphoma Diagnosis and Treatment |
| topics[1].id | https://openalex.org/T11811 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9995999932289124 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2708 |
| topics[1].subfield.display_name | Dermatology |
| topics[1].display_name | Cutaneous lymphoproliferative disorders research |
| topics[2].id | https://openalex.org/T10685 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9994999766349792 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | Viral-associated cancers and disorders |
| funders[0].id | https://openalex.org/F4320307115 |
| funders[0].ror | https://ror.org/00gtmwv55 |
| funders[0].display_name | Bristol-Myers Squibb |
| is_xpac | False |
| apc_list.value | 6300 |
| apc_list.currency | USD |
| apc_list.value_usd | 6300 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9271290302276611 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2776239401 |
| concepts[1].level | 5 |
| concepts[1].score | 0.7846702337265015 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q416451 |
| concepts[1].display_name | Azacitidine |
| concepts[2].id | https://openalex.org/C3019800554 |
| concepts[2].level | 3 |
| concepts[2].score | 0.7414786219596863 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q3813242 |
| concepts[2].display_name | Open label |
| concepts[3].id | https://openalex.org/C142424586 |
| concepts[3].level | 2 |
| concepts[3].score | 0.670759916305542 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q7307572 |
| concepts[3].display_name | Refractory (planetary science) |
| concepts[4].id | https://openalex.org/C126322002 |
| concepts[4].level | 1 |
| concepts[4].score | 0.568405270576477 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[4].display_name | Internal medicine |
| concepts[5].id | https://openalex.org/C2777058707 |
| concepts[5].level | 3 |
| concepts[5].score | 0.5193049311637878 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q123251 |
| concepts[5].display_name | Follicular lymphoma |
| concepts[6].id | https://openalex.org/C143998085 |
| concepts[6].level | 1 |
| concepts[6].score | 0.49707773327827454 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[6].display_name | Oncology |
| concepts[7].id | https://openalex.org/C187785154 |
| concepts[7].level | 2 |
| concepts[7].score | 0.46245551109313965 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q5464664 |
| concepts[7].display_name | Follicular phase |
| concepts[8].id | https://openalex.org/C31760486 |
| concepts[8].level | 3 |
| concepts[8].score | 0.4162139892578125 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q7180990 |
| concepts[8].display_name | Phases of clinical research |
| concepts[9].id | https://openalex.org/C2779338263 |
| concepts[9].level | 2 |
| concepts[9].score | 0.40817102789878845 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q208414 |
| concepts[9].display_name | Lymphoma |
| concepts[10].id | https://openalex.org/C535046627 |
| concepts[10].level | 2 |
| concepts[10].score | 0.3563733696937561 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q30612 |
| concepts[10].display_name | Clinical trial |
| concepts[11].id | https://openalex.org/C55493867 |
| concepts[11].level | 1 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[11].display_name | Biochemistry |
| concepts[12].id | https://openalex.org/C190727270 |
| concepts[12].level | 4 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q874745 |
| concepts[12].display_name | DNA methylation |
| concepts[13].id | https://openalex.org/C87355193 |
| concepts[13].level | 1 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q411 |
| concepts[13].display_name | Astrobiology |
| concepts[14].id | https://openalex.org/C121332964 |
| concepts[14].level | 0 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q413 |
| concepts[14].display_name | Physics |
| concepts[15].id | https://openalex.org/C104317684 |
| concepts[15].level | 2 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[15].display_name | Gene |
| concepts[16].id | https://openalex.org/C185592680 |
| concepts[16].level | 0 |
| concepts[16].score | 0.0 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[16].display_name | Chemistry |
| concepts[17].id | https://openalex.org/C150194340 |
| concepts[17].level | 3 |
| concepts[17].score | 0.0 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q26972 |
| concepts[17].display_name | Gene expression |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9271290302276611 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/azacitidine |
| keywords[1].score | 0.7846702337265015 |
| keywords[1].display_name | Azacitidine |
| keywords[2].id | https://openalex.org/keywords/open-label |
| keywords[2].score | 0.7414786219596863 |
| keywords[2].display_name | Open label |
| keywords[3].id | https://openalex.org/keywords/refractory |
| keywords[3].score | 0.670759916305542 |
| keywords[3].display_name | Refractory (planetary science) |
| keywords[4].id | https://openalex.org/keywords/internal-medicine |
| keywords[4].score | 0.568405270576477 |
| keywords[4].display_name | Internal medicine |
| keywords[5].id | https://openalex.org/keywords/follicular-lymphoma |
| keywords[5].score | 0.5193049311637878 |
| keywords[5].display_name | Follicular lymphoma |
| keywords[6].id | https://openalex.org/keywords/oncology |
| keywords[6].score | 0.49707773327827454 |
| keywords[6].display_name | Oncology |
| keywords[7].id | https://openalex.org/keywords/follicular-phase |
| keywords[7].score | 0.46245551109313965 |
| keywords[7].display_name | Follicular phase |
| keywords[8].id | https://openalex.org/keywords/phases-of-clinical-research |
| keywords[8].score | 0.4162139892578125 |
| keywords[8].display_name | Phases of clinical research |
| keywords[9].id | https://openalex.org/keywords/lymphoma |
| keywords[9].score | 0.40817102789878845 |
| keywords[9].display_name | Lymphoma |
| keywords[10].id | https://openalex.org/keywords/clinical-trial |
| keywords[10].score | 0.3563733696937561 |
| keywords[10].display_name | Clinical trial |
| language | en |
| locations[0].id | doi:10.1016/s2352-3026(24)00102-9 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S2531671668 |
| locations[0].source.issn | 2352-3026, 2451-9960 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 2352-3026 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | The Lancet Haematology |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | The Lancet Haematology |
| locations[0].landing_page_url | https://doi.org/10.1016/s2352-3026(24)00102-9 |
| locations[1].id | pmid:38796193 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | The Lancet. Haematology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38796193 |
| locations[2].id | pmh:oai:pure.atira.dk:openaire/080ee718-8915-41f7-83bc-fd7117004f02 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306400216 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Research Portal (King's College London) |
| locations[2].source.host_organization | https://openalex.org/I183935753 |
| locations[2].source.host_organization_name | King's College London |
| locations[2].source.host_organization_lineage | https://openalex.org/I183935753 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Dupuis, J, Bachy, E, Morschhauser, F, Cartron, G, Fukuhara, N, Daguindau, N, Casasnovas, R O, Snauwaert, S, Gressin, R, Fox, C P, d'Amore, F A, Staber, P B, Tournilhac, O, Bouabdallah, K, Thieblemont, C, André, M, Rai, S, Ennishi, D, Gkasiamis, A, Nishio, M, Fornecker, L M, Delfau-Larue, M H, Sako, N, Mule, S, de Leval, L, Gaulard, P, Tsukasaki, K & Lemonnier, F 2024, 'Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE) : an open-label randomised, phase 3 study', The Lancet Haematology, vol. 11, no. 6, pp. e406-e414. https://doi.org/10.1016/S2352-3026(24)00102-9 |
| locations[2].landing_page_url | https://pure.au.dk/portal/en/publications/080ee718-8915-41f7-83bc-fd7117004f02 |
| locations[3].id | pmh:oai:dial.uclouvain.be:boreal:289637 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S4306400166 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | Digital Access to Libraries |
| locations[3].source.host_organization | https://openalex.org/I2800384882 |
| locations[3].source.host_organization_name | Harris County Public Library |
| locations[3].source.host_organization_lineage | https://openalex.org/I2800384882 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | info:eu-repo/semantics/article |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | The Lancet. Haematology, Vol. 11, no.6, p. e406-e414 (2024) |
| locations[3].landing_page_url | http://hdl.handle.net/2078.1/289637 |
| locations[4].id | pmh:oai:serval.unil.ch:BIB_90411DAD960E |
| locations[4].is_oa | False |
| locations[4].source.id | https://openalex.org/S4306401797 |
| locations[4].source.issn | |
| locations[4].source.type | repository |
| locations[4].source.is_oa | False |
| locations[4].source.issn_l | |
| locations[4].source.is_core | False |
| locations[4].source.is_in_doaj | False |
| locations[4].source.display_name | SERVAL (Université de Lausanne) |
| locations[4].source.host_organization | https://openalex.org/I4210093590 |
| locations[4].source.host_organization_name | Swiss School of Archaeology in Greece |
| locations[4].source.host_organization_lineage | https://openalex.org/I4210093590 |
| locations[4].license | |
| locations[4].pdf_url | |
| locations[4].version | submittedVersion |
| locations[4].raw_type | article |
| locations[4].license_id | |
| locations[4].is_accepted | False |
| locations[4].is_published | False |
| locations[4].raw_source_name | The Lancet. Haematology, vol. 11, no. 6, pp. e406-e414 |
| locations[4].landing_page_url | https://serval.unil.ch/notice/serval:BIB_90411DAD960E |
| locations[5].id | pmh:oai:HAL:hal-04627240v1 |
| locations[5].is_oa | False |
| locations[5].source.id | https://openalex.org/S4306402512 |
| locations[5].source.issn | |
| locations[5].source.type | repository |
| locations[5].source.is_oa | False |
| locations[5].source.issn_l | |
| locations[5].source.is_core | False |
| locations[5].source.is_in_doaj | False |
| locations[5].source.display_name | HAL (Le Centre pour la Communication Scientifique Directe) |
| locations[5].source.host_organization | https://openalex.org/I1294671590 |
| locations[5].source.host_organization_name | Centre National de la Recherche Scientifique |
| locations[5].source.host_organization_lineage | https://openalex.org/I1294671590 |
| locations[5].license | |
| locations[5].pdf_url | |
| locations[5].version | submittedVersion |
| locations[5].raw_type | Journal articles |
| locations[5].license_id | |
| locations[5].is_accepted | False |
| locations[5].is_published | False |
| locations[5].raw_source_name | The Lancet Haematology, 2024, The Lancet Haematology, 11, pp.e406-e414. ⟨10.1016/S2352-3026(24)00102-9⟩ |
| locations[5].landing_page_url | https://hal.univ-lille.fr/hal-04627240 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5007139107 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Jehan Dupuis |
| authorships[0].countries | FR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210097159, https://openalex.org/I4210156254 |
| authorships[0].affiliations[0].raw_affiliation_string | Service d'Hématologie Lymphoïde, AP-HP, Groupe hospitalo-universitaire Chenevier Mondor, Créteil, France |
| authorships[0].institutions[0].id | https://openalex.org/I4210097159 |
| authorships[0].institutions[0].ror | https://ror.org/00pg5jh14 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210097159 |
| authorships[0].institutions[0].country_code | FR |
| authorships[0].institutions[0].display_name | Assistance Publique – Hôpitaux de Paris |
| authorships[0].institutions[1].id | https://openalex.org/I4210156254 |
| authorships[0].institutions[1].ror | https://ror.org/0511th722 |
| authorships[0].institutions[1].type | healthcare |
| authorships[0].institutions[1].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210156254 |
| authorships[0].institutions[1].country_code | FR |
| authorships[0].institutions[1].display_name | Hôpital Albert-Chenevier |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Jehan Dupuis |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Service d'Hématologie Lymphoïde, AP-HP, Groupe hospitalo-universitaire Chenevier Mondor, Créteil, France |
| authorships[1].author.id | https://openalex.org/A5053019069 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-2694-7510 |
| authorships[1].author.display_name | Emmanuel Bachy |
| authorships[1].countries | FR |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210100596 |
| authorships[1].affiliations[0].raw_affiliation_string | Service d'Hématologie Clinique, CHU Lyon Sud—Hospices Civils de Lyon, Pierre Bénite, France |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I100532134, https://openalex.org/I154526488, https://openalex.org/I4210161906 |
| authorships[1].affiliations[1].raw_affiliation_string | Inserm U1111, International Center for Infectiology Research (CIRI), Lyon, France |
| authorships[1].institutions[0].id | https://openalex.org/I4210161906 |
| authorships[1].institutions[0].ror | https://ror.org/059sz6q14 |
| authorships[1].institutions[0].type | facility |
| authorships[1].institutions[0].lineage | https://openalex.org/I100532134, https://openalex.org/I113428412, https://openalex.org/I1294671590, https://openalex.org/I154526488, https://openalex.org/I203339264, https://openalex.org/I4210100596, https://openalex.org/I4210161906, https://openalex.org/I4412460541 |
| authorships[1].institutions[0].country_code | FR |
| authorships[1].institutions[0].display_name | Centre International de Recherche en Infectiologie |
| authorships[1].institutions[1].id | https://openalex.org/I4210100596 |
| authorships[1].institutions[1].ror | https://ror.org/01502ca60 |
| authorships[1].institutions[1].type | healthcare |
| authorships[1].institutions[1].lineage | https://openalex.org/I4210100596 |
| authorships[1].institutions[1].country_code | FR |
| authorships[1].institutions[1].display_name | Hospices Civils de Lyon |
| authorships[1].institutions[2].id | https://openalex.org/I154526488 |
| authorships[1].institutions[2].ror | https://ror.org/02vjkv261 |
| authorships[1].institutions[2].type | government |
| authorships[1].institutions[2].lineage | https://openalex.org/I154526488 |
| authorships[1].institutions[2].country_code | FR |
| authorships[1].institutions[2].display_name | Inserm |
| authorships[1].institutions[3].id | https://openalex.org/I100532134 |
| authorships[1].institutions[3].ror | https://ror.org/029brtt94 |
| authorships[1].institutions[3].type | education |
| authorships[1].institutions[3].lineage | https://openalex.org/I100532134, https://openalex.org/I203339264 |
| authorships[1].institutions[3].country_code | FR |
| authorships[1].institutions[3].display_name | Université Claude Bernard Lyon 1 |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Emmanuel Bachy |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Inserm U1111, International Center for Infectiology Research (CIRI), Lyon, France, Service d'Hématologie Clinique, CHU Lyon Sud—Hospices Civils de Lyon, Pierre Bénite, France |
| authorships[2].author.id | https://openalex.org/A5050314863 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Franck Morschhauser |
| authorships[2].countries | FR |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I2279609970, https://openalex.org/I3018718406 |
| authorships[2].affiliations[0].raw_affiliation_string | Service des Maladies du Sang, ULR 7365—GRITA—Groupe de Recherche sur les formes Injectables et les Technologies Associées, CHU Lille, University of Lille, Lille, France |
| authorships[2].institutions[0].id | https://openalex.org/I3018718406 |
| authorships[2].institutions[0].ror | https://ror.org/02ppyfa04 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I3018718406 |
| authorships[2].institutions[0].country_code | FR |
| authorships[2].institutions[0].display_name | Centre Hospitalier Universitaire de Lille |
| authorships[2].institutions[1].id | https://openalex.org/I2279609970 |
| authorships[2].institutions[1].ror | https://ror.org/02kzqn938 |
| authorships[2].institutions[1].type | education |
| authorships[2].institutions[1].lineage | https://openalex.org/I2279609970 |
| authorships[2].institutions[1].country_code | FR |
| authorships[2].institutions[1].display_name | Université de Lille |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Franck Morschhauser |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Service des Maladies du Sang, ULR 7365—GRITA—Groupe de Recherche sur les formes Injectables et les Technologies Associées, CHU Lille, University of Lille, Lille, France |
| authorships[3].author.id | https://openalex.org/A5031977714 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-0659-9635 |
| authorships[3].author.display_name | Guillaume Cartron |
| authorships[3].countries | FR |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I1294671590, https://openalex.org/I4210093292 |
| authorships[3].affiliations[0].raw_affiliation_string | Département d'Hématologie Clinique, CHU de Montpellier—UMR-CNRS 5535, Montpellier, France |
| authorships[3].institutions[0].id | https://openalex.org/I4210093292 |
| authorships[3].institutions[0].ror | https://ror.org/00mthsf17 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210093292 |
| authorships[3].institutions[0].country_code | FR |
| authorships[3].institutions[0].display_name | Centre Hospitalier Universitaire de Montpellier |
| authorships[3].institutions[1].id | https://openalex.org/I1294671590 |
| authorships[3].institutions[1].ror | https://ror.org/02feahw73 |
| authorships[3].institutions[1].type | government |
| authorships[3].institutions[1].lineage | https://openalex.org/I1294671590 |
| authorships[3].institutions[1].country_code | FR |
| authorships[3].institutions[1].display_name | Centre National de la Recherche Scientifique |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Guillaume Cartron |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Département d'Hématologie Clinique, CHU de Montpellier—UMR-CNRS 5535, Montpellier, France |
| authorships[4].author.id | https://openalex.org/A5055192416 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-2682-2179 |
| authorships[4].author.display_name | Noriko Fukuhara |
| authorships[4].countries | JP |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210093896 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Hematology, Tohoku University Hospital, Sendai, Japan |
| authorships[4].institutions[0].id | https://openalex.org/I4210093896 |
| authorships[4].institutions[0].ror | https://ror.org/00kcd6x60 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210093896 |
| authorships[4].institutions[0].country_code | JP |
| authorships[4].institutions[0].display_name | Tohoku University Hospital |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Noriko Fukuhara |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Hematology, Tohoku University Hospital, Sendai, Japan |
| authorships[5].author.id | https://openalex.org/A5085150178 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Nicolas Daguindau |
| authorships[5].countries | FR |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210133838 |
| authorships[5].affiliations[0].raw_affiliation_string | Service Hématologie Clinique, Centre Hospitalier Annecy Genevois, Pringy, France |
| authorships[5].institutions[0].id | https://openalex.org/I4210133838 |
| authorships[5].institutions[0].ror | https://ror.org/03deam493 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210133838 |
| authorships[5].institutions[0].country_code | FR |
| authorships[5].institutions[0].display_name | Centre Hospitalier Annecy Genevois |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Nicolas Daguindau |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Service Hématologie Clinique, Centre Hospitalier Annecy Genevois, Pringy, France |
| authorships[6].author.id | https://openalex.org/A5062305482 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-1156-8983 |
| authorships[6].author.display_name | Olivier Casasnovas |
| authorships[6].countries | FR |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I4210116240 |
| authorships[6].affiliations[0].raw_affiliation_string | Service d'Hématologie Clinique, CHU de Dijon, Inserm U1231, Dijon, France |
| authorships[6].institutions[0].id | https://openalex.org/I4210116240 |
| authorships[6].institutions[0].ror | https://ror.org/0377z4z10 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210116240 |
| authorships[6].institutions[0].country_code | FR |
| authorships[6].institutions[0].display_name | CHU Dijon Bourgogne |
| authorships[6].institutions[1].id | https://openalex.org/I154526488 |
| authorships[6].institutions[1].ror | https://ror.org/02vjkv261 |
| authorships[6].institutions[1].type | government |
| authorships[6].institutions[1].lineage | https://openalex.org/I154526488 |
| authorships[6].institutions[1].country_code | FR |
| authorships[6].institutions[1].display_name | Inserm |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | René-Olivier Casasnovas |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Service d'Hématologie Clinique, CHU de Dijon, Inserm U1231, Dijon, France |
| authorships[7].author.id | https://openalex.org/A5082232325 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Sylvia Snauwaert |
| authorships[7].countries | BE |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210123377 |
| authorships[7].affiliations[0].raw_affiliation_string | Department of Hematology, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium |
| authorships[7].institutions[0].id | https://openalex.org/I4210123377 |
| authorships[7].institutions[0].ror | https://ror.org/030h1vb90 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210123377 |
| authorships[7].institutions[0].country_code | BE |
| authorships[7].institutions[0].display_name | AZ Sint-Jan |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Sylvia Snauwaert |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Department of Hematology, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium |
| authorships[8].author.id | https://openalex.org/A5074402846 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-9188-3501 |
| authorships[8].author.display_name | Rémy Gressin |
| authorships[8].countries | FR |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I2800555055, https://openalex.org/I4210162920 |
| authorships[8].affiliations[0].raw_affiliation_string | Service Hématologie Clinique, CHU de Grenoble—Hôpital Albert Michallon, Grenoble, France |
| authorships[8].institutions[0].id | https://openalex.org/I2800555055 |
| authorships[8].institutions[0].ror | https://ror.org/041rhpw39 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I2800555055 |
| authorships[8].institutions[0].country_code | FR |
| authorships[8].institutions[0].display_name | Centre Hospitalier Universitaire de Grenoble |
| authorships[8].institutions[1].id | https://openalex.org/I4210162920 |
| authorships[8].institutions[1].ror | https://ror.org/05kfvx519 |
| authorships[8].institutions[1].type | healthcare |
| authorships[8].institutions[1].lineage | https://openalex.org/I2800555055, https://openalex.org/I4210162920 |
| authorships[8].institutions[1].country_code | FR |
| authorships[8].institutions[1].display_name | Hôpital Albert Michallon |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Remy Gressin |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Service Hématologie Clinique, CHU de Grenoble—Hôpital Albert Michallon, Grenoble, France |
| authorships[9].author.id | https://openalex.org/A5082526059 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-6322-9254 |
| authorships[9].author.display_name | Christopher P. Fox |
| authorships[9].countries | GB |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I142263535 |
| authorships[9].affiliations[0].raw_affiliation_string | School of Medicine, University of Nottingham, Nottingham, UK |
| authorships[9].institutions[0].id | https://openalex.org/I142263535 |
| authorships[9].institutions[0].ror | https://ror.org/01ee9ar58 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I142263535 |
| authorships[9].institutions[0].country_code | GB |
| authorships[9].institutions[0].display_name | University of Nottingham |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Christopher P Fox |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | School of Medicine, University of Nottingham, Nottingham, UK |
| authorships[10].author.id | https://openalex.org/A5008827664 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Francesco d’Amore |
| authorships[10].countries | DK |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I2802335433 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Hematology, Aarhus University Hospital, Aarhus Nord, Denmark |
| authorships[10].institutions[0].id | https://openalex.org/I2802335433 |
| authorships[10].institutions[0].ror | https://ror.org/040r8fr65 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I2802335433 |
| authorships[10].institutions[0].country_code | DK |
| authorships[10].institutions[0].display_name | Aarhus University Hospital |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Francesco Annibale d’Amore |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Hematology, Aarhus University Hospital, Aarhus Nord, Denmark |
| authorships[11].author.id | https://openalex.org/A5027978059 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-6729-7708 |
| authorships[11].author.display_name | Philipp B. Staber |
| authorships[11].countries | AT |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I76134821 |
| authorships[11].affiliations[0].raw_affiliation_string | Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria |
| authorships[11].institutions[0].id | https://openalex.org/I76134821 |
| authorships[11].institutions[0].ror | https://ror.org/05n3x4p02 |
| authorships[11].institutions[0].type | education |
| authorships[11].institutions[0].lineage | https://openalex.org/I76134821 |
| authorships[11].institutions[0].country_code | AT |
| authorships[11].institutions[0].display_name | Medical University of Vienna |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Philipp B Staber |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria |
| authorships[12].author.id | https://openalex.org/A5052071966 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-9438-621X |
| authorships[12].author.display_name | Olivier Tournilhac |
| authorships[12].countries | FR |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210128870 |
| authorships[12].affiliations[0].raw_affiliation_string | Service d'Hématologie Clinique et de Thérapie Cellulaire Adulte, CHU de Clermont-Ferrand—Hôpital Estaing, Clermont-Ferrand, France |
| authorships[12].institutions[0].id | https://openalex.org/I4210128870 |
| authorships[12].institutions[0].ror | https://ror.org/02tcf7a68 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I4210128870 |
| authorships[12].institutions[0].country_code | FR |
| authorships[12].institutions[0].display_name | Centre Hospitalier Universitaire de Clermont-Ferrand |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Olivier Tournilhac |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Service d'Hématologie Clinique et de Thérapie Cellulaire Adulte, CHU de Clermont-Ferrand—Hôpital Estaing, Clermont-Ferrand, France |
| authorships[13].author.id | https://openalex.org/A5068452218 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-4425-7823 |
| authorships[13].author.display_name | Krimo Bouabdallah |
| authorships[13].countries | FR |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I3018323443, https://openalex.org/I4210120975 |
| authorships[13].affiliations[0].raw_affiliation_string | Service d'Hématologie Clinique et Thérapie Cellulaire, CHU de Bordeaux—Hôpital Haut Lévêque—Centre François Magendie, Pessac, France |
| authorships[13].institutions[0].id | https://openalex.org/I3018323443 |
| authorships[13].institutions[0].ror | https://ror.org/01hq89f96 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I3018323443 |
| authorships[13].institutions[0].country_code | FR |
| authorships[13].institutions[0].display_name | Centre Hospitalier Universitaire de Bordeaux |
| authorships[13].institutions[1].id | https://openalex.org/I4210120975 |
| authorships[13].institutions[1].ror | https://ror.org/02bf3a828 |
| authorships[13].institutions[1].type | healthcare |
| authorships[13].institutions[1].lineage | https://openalex.org/I3018323443, https://openalex.org/I4210120975 |
| authorships[13].institutions[1].country_code | FR |
| authorships[13].institutions[1].display_name | Hôpital Cardiologique du Haut-Lévêque |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Krimo Bouabdallah |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Service d'Hématologie Clinique et Thérapie Cellulaire, CHU de Bordeaux—Hôpital Haut Lévêque—Centre François Magendie, Pessac, France |
| authorships[14].author.id | https://openalex.org/A5073089715 |
| authorships[14].author.orcid | |
| authorships[14].author.display_name | Catherine Thieblemont |
| authorships[14].countries | FR |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I204730241 |
| authorships[14].affiliations[0].raw_affiliation_string | Université Paris Cité, Paris, France |
| authorships[14].affiliations[1].institution_ids | https://openalex.org/I4210097159, https://openalex.org/I4210144610 |
| authorships[14].affiliations[1].raw_affiliation_string | Service d'hémato-oncologie, Assistance Publique–Hôpitaux de Paris, Hôpital Saint Louis, Paris, France |
| authorships[14].institutions[0].id | https://openalex.org/I4210097159 |
| authorships[14].institutions[0].ror | https://ror.org/00pg5jh14 |
| authorships[14].institutions[0].type | healthcare |
| authorships[14].institutions[0].lineage | https://openalex.org/I4210097159 |
| authorships[14].institutions[0].country_code | FR |
| authorships[14].institutions[0].display_name | Assistance Publique – Hôpitaux de Paris |
| authorships[14].institutions[1].id | https://openalex.org/I4210144610 |
| authorships[14].institutions[1].ror | https://ror.org/049am9t04 |
| authorships[14].institutions[1].type | healthcare |
| authorships[14].institutions[1].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210144610 |
| authorships[14].institutions[1].country_code | FR |
| authorships[14].institutions[1].display_name | Hôpital Saint-Louis |
| authorships[14].institutions[2].id | https://openalex.org/I204730241 |
| authorships[14].institutions[2].ror | https://ror.org/05f82e368 |
| authorships[14].institutions[2].type | education |
| authorships[14].institutions[2].lineage | https://openalex.org/I204730241 |
| authorships[14].institutions[2].country_code | FR |
| authorships[14].institutions[2].display_name | Université Paris Cité |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Catherine Thieblemont |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Service d'hémato-oncologie, Assistance Publique–Hôpitaux de Paris, Hôpital Saint Louis, Paris, France, Université Paris Cité, Paris, France |
| authorships[15].author.id | https://openalex.org/A5061562207 |
| authorships[15].author.orcid | |
| authorships[15].author.display_name | Marc André |
| authorships[15].countries | BE |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I4210093617 |
| authorships[15].affiliations[0].raw_affiliation_string | Service Hématologie, CHU UCL Namur—Site Godinne, Yvoir, Belgium |
| authorships[15].institutions[0].id | https://openalex.org/I4210093617 |
| authorships[15].institutions[0].ror | https://ror.org/00ntbvq76 |
| authorships[15].institutions[0].type | healthcare |
| authorships[15].institutions[0].lineage | https://openalex.org/I4210093617 |
| authorships[15].institutions[0].country_code | BE |
| authorships[15].institutions[0].display_name | CHU Dinant Godinne UCL Namur |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Marc André |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Service Hématologie, CHU UCL Namur—Site Godinne, Yvoir, Belgium |
| authorships[16].author.id | https://openalex.org/A5004550999 |
| authorships[16].author.orcid | https://orcid.org/0000-0003-3929-9751 |
| authorships[16].author.display_name | Shinya Rai |
| authorships[16].countries | JP |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I4210094884 |
| authorships[16].affiliations[0].raw_affiliation_string | Department of Hematology & Rheumatology, Kindai University Hospital, Osakasayama, Japan |
| authorships[16].institutions[0].id | https://openalex.org/I4210094884 |
| authorships[16].institutions[0].ror | https://ror.org/00qmnd673 |
| authorships[16].institutions[0].type | healthcare |
| authorships[16].institutions[0].lineage | https://openalex.org/I4210094884 |
| authorships[16].institutions[0].country_code | JP |
| authorships[16].institutions[0].display_name | Kindai University Hospital |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Shinya Rai |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Department of Hematology & Rheumatology, Kindai University Hospital, Osakasayama, Japan |
| authorships[17].author.id | https://openalex.org/A5061361157 |
| authorships[17].author.orcid | https://orcid.org/0000-0003-4788-2103 |
| authorships[17].author.display_name | Daisuke Ennishi |
| authorships[17].countries | JP |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I4210100185 |
| authorships[17].affiliations[0].raw_affiliation_string | Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan |
| authorships[17].institutions[0].id | https://openalex.org/I4210100185 |
| authorships[17].institutions[0].ror | https://ror.org/019tepx80 |
| authorships[17].institutions[0].type | healthcare |
| authorships[17].institutions[0].lineage | https://openalex.org/I4210100185 |
| authorships[17].institutions[0].country_code | JP |
| authorships[17].institutions[0].display_name | Okayama University Hospital |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Daisuke Ennishi |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan |
| authorships[18].author.id | https://openalex.org/A5047255931 |
| authorships[18].author.orcid | |
| authorships[18].author.display_name | Argyrios Gkasiamis |
| authorships[18].countries | CH |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I47396830 |
| authorships[18].affiliations[0].raw_affiliation_string | Bristol Myers Squibb, Neuchâtel, Switzerland |
| authorships[18].institutions[0].id | https://openalex.org/I47396830 |
| authorships[18].institutions[0].ror | https://ror.org/02xqc6638 |
| authorships[18].institutions[0].type | company |
| authorships[18].institutions[0].lineage | https://openalex.org/I4210091812, https://openalex.org/I47396830 |
| authorships[18].institutions[0].country_code | CH |
| authorships[18].institutions[0].display_name | Bristol-Myers Squibb (Switzerland) |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Argyrios Gkasiamis |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Bristol Myers Squibb, Neuchâtel, Switzerland |
| authorships[19].author.id | https://openalex.org/A5082414060 |
| authorships[19].author.orcid | |
| authorships[19].author.display_name | Mitsufumi Nishio |
| authorships[19].countries | JP |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I4210148404 |
| authorships[19].affiliations[0].raw_affiliation_string | Bristol Myers Squibb, Tokyo, Japan |
| authorships[19].institutions[0].id | https://openalex.org/I4210148404 |
| authorships[19].institutions[0].ror | https://ror.org/04dbmrm19 |
| authorships[19].institutions[0].type | company |
| authorships[19].institutions[0].lineage | https://openalex.org/I4210091812, https://openalex.org/I4210148404 |
| authorships[19].institutions[0].country_code | JP |
| authorships[19].institutions[0].display_name | Bristol-Myers Squibb (Japan) |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Mitsufumi Nishio |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | Bristol Myers Squibb, Tokyo, Japan |
| authorships[20].author.id | https://openalex.org/A5024972342 |
| authorships[20].author.orcid | https://orcid.org/0000-0002-1866-971X |
| authorships[20].author.display_name | Luc‐Matthieu Fornecker |
| authorships[20].countries | FR |
| authorships[20].affiliations[0].institution_ids | https://openalex.org/I68947357 |
| authorships[20].affiliations[0].raw_affiliation_string | University of Strasbourg, Strasbourg, France |
| authorships[20].affiliations[1].institution_ids | https://openalex.org/I4210090340 |
| authorships[20].affiliations[1].raw_affiliation_string | Institut de Cancérologie Strasbourg Europe (ICANS) Strasbourg, France |
| authorships[20].institutions[0].id | https://openalex.org/I4210090340 |
| authorships[20].institutions[0].ror | https://ror.org/008fdbn61 |
| authorships[20].institutions[0].type | healthcare |
| authorships[20].institutions[0].lineage | https://openalex.org/I4210090340 |
| authorships[20].institutions[0].country_code | FR |
| authorships[20].institutions[0].display_name | Institut de Cancérologie Strasbourg |
| authorships[20].institutions[1].id | https://openalex.org/I68947357 |
| authorships[20].institutions[1].ror | https://ror.org/00pg6eq24 |
| authorships[20].institutions[1].type | education |
| authorships[20].institutions[1].lineage | https://openalex.org/I68947357 |
| authorships[20].institutions[1].country_code | FR |
| authorships[20].institutions[1].display_name | Université de Strasbourg |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Luc-Matthieu Fornecker |
| authorships[20].is_corresponding | False |
| authorships[20].raw_affiliation_strings | Institut de Cancérologie Strasbourg Europe (ICANS) Strasbourg, France, University of Strasbourg, Strasbourg, France |
| authorships[21].author.id | https://openalex.org/A5072246038 |
| authorships[21].author.orcid | https://orcid.org/0000-0002-8010-2343 |
| authorships[21].author.display_name | Marie‐Hélène Delfau‐Larue |
| authorships[21].countries | FR |
| authorships[21].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I197681013, https://openalex.org/I4210159433 |
| authorships[21].affiliations[0].raw_affiliation_string | IMRB, INSERM, Université Paris Est Créteil, Créteil, France |
| authorships[21].affiliations[1].institution_ids | https://openalex.org/I4210097159, https://openalex.org/I4210156254 |
| authorships[21].affiliations[1].raw_affiliation_string | Laboratoire d'immunologie, AP-HP, Groupe hospitalo-universitaire Chenevier Mondor, Créteil, France |
| authorships[21].institutions[0].id | https://openalex.org/I4210097159 |
| authorships[21].institutions[0].ror | https://ror.org/00pg5jh14 |
| authorships[21].institutions[0].type | healthcare |
| authorships[21].institutions[0].lineage | https://openalex.org/I4210097159 |
| authorships[21].institutions[0].country_code | FR |
| authorships[21].institutions[0].display_name | Assistance Publique – Hôpitaux de Paris |
| authorships[21].institutions[1].id | https://openalex.org/I4210156254 |
| authorships[21].institutions[1].ror | https://ror.org/0511th722 |
| authorships[21].institutions[1].type | healthcare |
| authorships[21].institutions[1].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210156254 |
| authorships[21].institutions[1].country_code | FR |
| authorships[21].institutions[1].display_name | Hôpital Albert-Chenevier |
| authorships[21].institutions[2].id | https://openalex.org/I154526488 |
| authorships[21].institutions[2].ror | https://ror.org/02vjkv261 |
| authorships[21].institutions[2].type | government |
| authorships[21].institutions[2].lineage | https://openalex.org/I154526488 |
| authorships[21].institutions[2].country_code | FR |
| authorships[21].institutions[2].display_name | Inserm |
| authorships[21].institutions[3].id | https://openalex.org/I4210159433 |
| authorships[21].institutions[3].ror | https://ror.org/04qe59j94 |
| authorships[21].institutions[3].type | facility |
| authorships[21].institutions[3].lineage | https://openalex.org/I154526488, https://openalex.org/I17606148, https://openalex.org/I197681013, https://openalex.org/I197681013, https://openalex.org/I4210159433 |
| authorships[21].institutions[3].country_code | FR |
| authorships[21].institutions[3].display_name | Institut Mondor de Recherche Biomédicale |
| authorships[21].institutions[4].id | https://openalex.org/I197681013 |
| authorships[21].institutions[4].ror | https://ror.org/05ggc9x40 |
| authorships[21].institutions[4].type | education |
| authorships[21].institutions[4].lineage | https://openalex.org/I197681013 |
| authorships[21].institutions[4].country_code | FR |
| authorships[21].institutions[4].display_name | Université Paris-Est Créteil |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Marie-Helene Delfau-Larue |
| authorships[21].is_corresponding | False |
| authorships[21].raw_affiliation_strings | IMRB, INSERM, Université Paris Est Créteil, Créteil, France, Laboratoire d'immunologie, AP-HP, Groupe hospitalo-universitaire Chenevier Mondor, Créteil, France |
| authorships[22].author.id | https://openalex.org/A5058214862 |
| authorships[22].author.orcid | https://orcid.org/0000-0002-4071-0088 |
| authorships[22].author.display_name | Nouhoum Sako |
| authorships[22].countries | FR |
| authorships[22].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I197681013, https://openalex.org/I4210159433 |
| authorships[22].affiliations[0].raw_affiliation_string | IMRB, INSERM, Université Paris Est Créteil, Créteil, France |
| authorships[22].institutions[0].id | https://openalex.org/I154526488 |
| authorships[22].institutions[0].ror | https://ror.org/02vjkv261 |
| authorships[22].institutions[0].type | government |
| authorships[22].institutions[0].lineage | https://openalex.org/I154526488 |
| authorships[22].institutions[0].country_code | FR |
| authorships[22].institutions[0].display_name | Inserm |
| authorships[22].institutions[1].id | https://openalex.org/I4210159433 |
| authorships[22].institutions[1].ror | https://ror.org/04qe59j94 |
| authorships[22].institutions[1].type | facility |
| authorships[22].institutions[1].lineage | https://openalex.org/I154526488, https://openalex.org/I17606148, https://openalex.org/I197681013, https://openalex.org/I197681013, https://openalex.org/I4210159433 |
| authorships[22].institutions[1].country_code | FR |
| authorships[22].institutions[1].display_name | Institut Mondor de Recherche Biomédicale |
| authorships[22].institutions[2].id | https://openalex.org/I197681013 |
| authorships[22].institutions[2].ror | https://ror.org/05ggc9x40 |
| authorships[22].institutions[2].type | education |
| authorships[22].institutions[2].lineage | https://openalex.org/I197681013 |
| authorships[22].institutions[2].country_code | FR |
| authorships[22].institutions[2].display_name | Université Paris-Est Créteil |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | Nouhoum Sako |
| authorships[22].is_corresponding | False |
| authorships[22].raw_affiliation_strings | IMRB, INSERM, Université Paris Est Créteil, Créteil, France |
| authorships[23].author.id | https://openalex.org/A5018253543 |
| authorships[23].author.orcid | https://orcid.org/0000-0002-6896-6149 |
| authorships[23].author.display_name | Sebastien Mulé |
| authorships[23].countries | FR |
| authorships[23].affiliations[0].institution_ids | https://openalex.org/I4210097159, https://openalex.org/I4210156254 |
| authorships[23].affiliations[0].raw_affiliation_string | Département d'imagerie médicale, AP-HP, Groupe hospitalo-universitaire Chenevier Mondor, Créteil, France |
| authorships[23].institutions[0].id | https://openalex.org/I4210097159 |
| authorships[23].institutions[0].ror | https://ror.org/00pg5jh14 |
| authorships[23].institutions[0].type | healthcare |
| authorships[23].institutions[0].lineage | https://openalex.org/I4210097159 |
| authorships[23].institutions[0].country_code | FR |
| authorships[23].institutions[0].display_name | Assistance Publique – Hôpitaux de Paris |
| authorships[23].institutions[1].id | https://openalex.org/I4210156254 |
| authorships[23].institutions[1].ror | https://ror.org/0511th722 |
| authorships[23].institutions[1].type | healthcare |
| authorships[23].institutions[1].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210156254 |
| authorships[23].institutions[1].country_code | FR |
| authorships[23].institutions[1].display_name | Hôpital Albert-Chenevier |
| authorships[23].author_position | middle |
| authorships[23].raw_author_name | Sebastien Mule |
| authorships[23].is_corresponding | False |
| authorships[23].raw_affiliation_strings | Département d'imagerie médicale, AP-HP, Groupe hospitalo-universitaire Chenevier Mondor, Créteil, France |
| authorships[24].author.id | https://openalex.org/A5074135845 |
| authorships[24].author.orcid | https://orcid.org/0000-0003-3994-516X |
| authorships[24].author.display_name | Laurence de Leval |
| authorships[24].countries | CH |
| authorships[24].affiliations[0].institution_ids | https://openalex.org/I97565354 |
| authorships[24].affiliations[0].raw_affiliation_string | Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Suisse |
| authorships[24].institutions[0].id | https://openalex.org/I97565354 |
| authorships[24].institutions[0].ror | https://ror.org/019whta54 |
| authorships[24].institutions[0].type | education |
| authorships[24].institutions[0].lineage | https://openalex.org/I97565354 |
| authorships[24].institutions[0].country_code | CH |
| authorships[24].institutions[0].display_name | University of Lausanne |
| authorships[24].author_position | middle |
| authorships[24].raw_author_name | Laurence de Leval |
| authorships[24].is_corresponding | False |
| authorships[24].raw_affiliation_strings | Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Suisse |
| authorships[25].author.id | https://openalex.org/A5012900514 |
| authorships[25].author.orcid | https://orcid.org/0000-0002-4243-905X |
| authorships[25].author.display_name | Philippe Gaulard |
| authorships[25].countries | FR |
| authorships[25].affiliations[0].institution_ids | https://openalex.org/I4210097159, https://openalex.org/I4210156254 |
| authorships[25].affiliations[0].raw_affiliation_string | Département de pathologie, AP-HP, Groupe hospitalo-universitaire Chenevier Mondor, Créteil, France |
| authorships[25].affiliations[1].institution_ids | https://openalex.org/I154526488, https://openalex.org/I197681013, https://openalex.org/I4210159433 |
| authorships[25].affiliations[1].raw_affiliation_string | IMRB, INSERM, Université Paris Est Créteil, Créteil, France |
| authorships[25].institutions[0].id | https://openalex.org/I4210097159 |
| authorships[25].institutions[0].ror | https://ror.org/00pg5jh14 |
| authorships[25].institutions[0].type | healthcare |
| authorships[25].institutions[0].lineage | https://openalex.org/I4210097159 |
| authorships[25].institutions[0].country_code | FR |
| authorships[25].institutions[0].display_name | Assistance Publique – Hôpitaux de Paris |
| authorships[25].institutions[1].id | https://openalex.org/I4210156254 |
| authorships[25].institutions[1].ror | https://ror.org/0511th722 |
| authorships[25].institutions[1].type | healthcare |
| authorships[25].institutions[1].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210156254 |
| authorships[25].institutions[1].country_code | FR |
| authorships[25].institutions[1].display_name | Hôpital Albert-Chenevier |
| authorships[25].institutions[2].id | https://openalex.org/I154526488 |
| authorships[25].institutions[2].ror | https://ror.org/02vjkv261 |
| authorships[25].institutions[2].type | government |
| authorships[25].institutions[2].lineage | https://openalex.org/I154526488 |
| authorships[25].institutions[2].country_code | FR |
| authorships[25].institutions[2].display_name | Inserm |
| authorships[25].institutions[3].id | https://openalex.org/I4210159433 |
| authorships[25].institutions[3].ror | https://ror.org/04qe59j94 |
| authorships[25].institutions[3].type | facility |
| authorships[25].institutions[3].lineage | https://openalex.org/I154526488, https://openalex.org/I17606148, https://openalex.org/I197681013, https://openalex.org/I197681013, https://openalex.org/I4210159433 |
| authorships[25].institutions[3].country_code | FR |
| authorships[25].institutions[3].display_name | Institut Mondor de Recherche Biomédicale |
| authorships[25].institutions[4].id | https://openalex.org/I197681013 |
| authorships[25].institutions[4].ror | https://ror.org/05ggc9x40 |
| authorships[25].institutions[4].type | education |
| authorships[25].institutions[4].lineage | https://openalex.org/I197681013 |
| authorships[25].institutions[4].country_code | FR |
| authorships[25].institutions[4].display_name | Université Paris-Est Créteil |
| authorships[25].author_position | middle |
| authorships[25].raw_author_name | Philippe Gaulard |
| authorships[25].is_corresponding | False |
| authorships[25].raw_affiliation_strings | Département de pathologie, AP-HP, Groupe hospitalo-universitaire Chenevier Mondor, Créteil, France, IMRB, INSERM, Université Paris Est Créteil, Créteil, France |
| authorships[26].author.id | https://openalex.org/A5049465924 |
| authorships[26].author.orcid | https://orcid.org/0000-0001-7219-5589 |
| authorships[26].author.display_name | Kunihiro Tsukasaki |
| authorships[26].countries | JP |
| authorships[26].affiliations[0].institution_ids | https://openalex.org/I8588240 |
| authorships[26].affiliations[0].raw_affiliation_string | Department of Hematology, International Medical Center, Saitama Medical University, Saitama, Japan |
| authorships[26].institutions[0].id | https://openalex.org/I8588240 |
| authorships[26].institutions[0].ror | https://ror.org/04zb31v77 |
| authorships[26].institutions[0].type | education |
| authorships[26].institutions[0].lineage | https://openalex.org/I8588240 |
| authorships[26].institutions[0].country_code | JP |
| authorships[26].institutions[0].display_name | Saitama Medical University |
| authorships[26].author_position | middle |
| authorships[26].raw_author_name | Kunihiro Tsukasaki |
| authorships[26].is_corresponding | False |
| authorships[26].raw_affiliation_strings | Department of Hematology, International Medical Center, Saitama Medical University, Saitama, Japan |
| authorships[27].author.id | https://openalex.org/A5037590260 |
| authorships[27].author.orcid | https://orcid.org/0000-0001-6205-5419 |
| authorships[27].author.display_name | François Lemonnier |
| authorships[27].countries | FR |
| authorships[27].affiliations[0].institution_ids | https://openalex.org/I4210097159, https://openalex.org/I4210156254 |
| authorships[27].affiliations[0].raw_affiliation_string | Service d'Hématologie Lymphoïde, AP-HP, Groupe hospitalo-universitaire Chenevier Mondor, Créteil, France |
| authorships[27].affiliations[1].institution_ids | https://openalex.org/I154526488, https://openalex.org/I197681013, https://openalex.org/I4210159433 |
| authorships[27].affiliations[1].raw_affiliation_string | IMRB, INSERM, Université Paris Est Créteil, Créteil, France |
| authorships[27].institutions[0].id | https://openalex.org/I4210097159 |
| authorships[27].institutions[0].ror | https://ror.org/00pg5jh14 |
| authorships[27].institutions[0].type | healthcare |
| authorships[27].institutions[0].lineage | https://openalex.org/I4210097159 |
| authorships[27].institutions[0].country_code | FR |
| authorships[27].institutions[0].display_name | Assistance Publique – Hôpitaux de Paris |
| authorships[27].institutions[1].id | https://openalex.org/I4210156254 |
| authorships[27].institutions[1].ror | https://ror.org/0511th722 |
| authorships[27].institutions[1].type | healthcare |
| authorships[27].institutions[1].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210156254 |
| authorships[27].institutions[1].country_code | FR |
| authorships[27].institutions[1].display_name | Hôpital Albert-Chenevier |
| authorships[27].institutions[2].id | https://openalex.org/I154526488 |
| authorships[27].institutions[2].ror | https://ror.org/02vjkv261 |
| authorships[27].institutions[2].type | government |
| authorships[27].institutions[2].lineage | https://openalex.org/I154526488 |
| authorships[27].institutions[2].country_code | FR |
| authorships[27].institutions[2].display_name | Inserm |
| authorships[27].institutions[3].id | https://openalex.org/I4210159433 |
| authorships[27].institutions[3].ror | https://ror.org/04qe59j94 |
| authorships[27].institutions[3].type | facility |
| authorships[27].institutions[3].lineage | https://openalex.org/I154526488, https://openalex.org/I17606148, https://openalex.org/I197681013, https://openalex.org/I197681013, https://openalex.org/I4210159433 |
| authorships[27].institutions[3].country_code | FR |
| authorships[27].institutions[3].display_name | Institut Mondor de Recherche Biomédicale |
| authorships[27].institutions[4].id | https://openalex.org/I197681013 |
| authorships[27].institutions[4].ror | https://ror.org/05ggc9x40 |
| authorships[27].institutions[4].type | education |
| authorships[27].institutions[4].lineage | https://openalex.org/I197681013 |
| authorships[27].institutions[4].country_code | FR |
| authorships[27].institutions[4].display_name | Université Paris-Est Créteil |
| authorships[27].author_position | last |
| authorships[27].raw_author_name | François Lemonnier |
| authorships[27].is_corresponding | False |
| authorships[27].raw_affiliation_strings | IMRB, INSERM, Université Paris Est Créteil, Créteil, France, Service d'Hématologie Lymphoïde, AP-HP, Groupe hospitalo-universitaire Chenevier Mondor, Créteil, France |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://pure.au.dk/portal/en/publications/080ee718-8915-41f7-83bc-fd7117004f02 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10185 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2734 |
| primary_topic.subfield.display_name | Pathology and Forensic Medicine |
| primary_topic.display_name | Lymphoma Diagnosis and Treatment |
| related_works | https://openalex.org/W1975382014, https://openalex.org/W2810120321, https://openalex.org/W2021963759, https://openalex.org/W2621173929, https://openalex.org/W2115106314, https://openalex.org/W1984303161, https://openalex.org/W2040459752, https://openalex.org/W2042704711, https://openalex.org/W4310753923, https://openalex.org/W4296531778 |
| cited_by_count | 18 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 15 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 3 |
| locations_count | 6 |
| best_oa_location.id | pmh:oai:pure.atira.dk:openaire/080ee718-8915-41f7-83bc-fd7117004f02 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4306400216 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Research Portal (King's College London) |
| best_oa_location.source.host_organization | https://openalex.org/I183935753 |
| best_oa_location.source.host_organization_name | King's College London |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I183935753 |
| best_oa_location.license | other-oa |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | article |
| best_oa_location.license_id | https://openalex.org/licenses/other-oa |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | Dupuis, J, Bachy, E, Morschhauser, F, Cartron, G, Fukuhara, N, Daguindau, N, Casasnovas, R O, Snauwaert, S, Gressin, R, Fox, C P, d'Amore, F A, Staber, P B, Tournilhac, O, Bouabdallah, K, Thieblemont, C, André, M, Rai, S, Ennishi, D, Gkasiamis, A, Nishio, M, Fornecker, L M, Delfau-Larue, M H, Sako, N, Mule, S, de Leval, L, Gaulard, P, Tsukasaki, K & Lemonnier, F 2024, 'Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE) : an open-label randomised, phase 3 study', The Lancet Haematology, vol. 11, no. 6, pp. e406-e414. https://doi.org/10.1016/S2352-3026(24)00102-9 |
| best_oa_location.landing_page_url | https://pure.au.dk/portal/en/publications/080ee718-8915-41f7-83bc-fd7117004f02 |
| primary_location.id | doi:10.1016/s2352-3026(24)00102-9 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S2531671668 |
| primary_location.source.issn | 2352-3026, 2451-9960 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 2352-3026 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | The Lancet Haematology |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | The Lancet Haematology |
| primary_location.landing_page_url | https://doi.org/10.1016/s2352-3026(24)00102-9 |
| publication_date | 2024-05-23 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W2416844197, https://openalex.org/W2171873783, https://openalex.org/W2116068882, https://openalex.org/W2109716912, https://openalex.org/W2146112074, https://openalex.org/W2610939428, https://openalex.org/W1780920458, https://openalex.org/W2088636620, https://openalex.org/W2579636005, https://openalex.org/W4283381496, https://openalex.org/W4281625438, https://openalex.org/W2028078153, https://openalex.org/W2074678620, https://openalex.org/W2146146853, https://openalex.org/W4233431843, https://openalex.org/W2120566462, https://openalex.org/W2036832665, https://openalex.org/W2772537975, https://openalex.org/W2158735008, https://openalex.org/W2073504536, https://openalex.org/W2472272437, https://openalex.org/W2894682501, https://openalex.org/W4285678301, https://openalex.org/W3100453931, https://openalex.org/W2119147717, https://openalex.org/W3125096684, https://openalex.org/W2795076534, https://openalex.org/W3114952208, https://openalex.org/W1605230984 |
| referenced_works_count | 29 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 100 |
| cited_by_percentile_year.min | 96 |
| corresponding_author_ids | https://openalex.org/A5007139107 |
| countries_distinct_count | 7 |
| institutions_distinct_count | 28 |
| corresponding_institution_ids | https://openalex.org/I4210097159, https://openalex.org/I4210156254 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/2 |
| sustainable_development_goals[0].score | 0.49000000953674316 |
| sustainable_development_goals[0].display_name | Zero hunger |
| citation_normalized_percentile.value | 0.98787596 |
| citation_normalized_percentile.is_in_top_1_percent | True |
| citation_normalized_percentile.is_in_top_10_percent | True |